|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 221/28 | (2006.01) |
| C07D 221/28 | (2013.01) | ||
| A61P 11/14 | (2006.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 25/24 | (2018.01) | ||
| A61P 11/14 | (2018.01) |
| (11) | Number of the document | 3825307 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20203704.0 |
| Date of filing the European patent application | 2017-07-03 | |
| (97) | Date of publication of the European application | 2021-05-26 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-03 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| PCT/CN2016/088414 | 2016-07-04 | WO |
| (72) |
JOHNSON, Matt , US
ZHAO, Cunxiang , CN
MENG, Weihua , CN
LU, Zhijun , CN
LI, Yan , CN
|
| (73) |
Avanir Pharmaceuticals, Inc. ,
30 Enterprise, Suite 200, Aliso Viejo, CA 92656,
US
|
| (54) | METHODS FOR THE SYNTHESIS OF DEUTERATED DEXTROMETHORPHAN |
| METHODS FOR THE SYNTHESIS OF DEUTERATED DEXTROMETHORPHAN |